Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Bingcao Wu, Gaurav Deshpande, Tao Gu, Breanna Popelar, Michael Philbin & George J. Wan. (2017) Demographics, treatment patterns, and healthcare utilization and cost of repository corticotropin injection in patients with systemic lupus erythematosus or rheumatoid arthritis. Journal of Medical Economics 20:11, pages 1170-1177.
Read now
Read now
Articles from other publishers (10)
Dora H Lin, Irene B Murimi-Worstell, Hong Kan, Jonothan C Tierce, Xia Wang, Henk Nab, Barnabas Desta, Edward R Hammond & G Caleb Alexander. (2022) Health care utilization and costs of systemic lupus erythematosus in the United States: A systematic review. Lupus 31:7, pages 773-807.
Crossref
Crossref
Christopher F Bell, Mayank R Ajmera & Juliana Meyers. (2022) An evaluation of costs associated with overall organ damage in patients with systemic lupus erythematosus in the United States. Lupus 31:2, pages 202-211.
Crossref
Crossref
Juliette C. Thompson, Anadi Mahajan, David A. Scott & Kerry Gairy. (2021) The Economic Burden of Lupus Nephritis: A Systematic Literature Review. Rheumatology and Therapy 9:1, pages 25-47.
Crossref
Crossref
Pedro Alves, Jigar Bandaria, Michelle B Leavy, Benjamin Gliklich, Costas Boussios, Zhaohui Su & Gary Curhan. (2021) Validation of a machine learning approach to estimate Systemic Lupus Erythematosus Disease Activity Index score categories and application in a real-world dataset. RMD Open 7:2, pages e001586.
Crossref
Crossref
Christopher F. Bell, Matthew Lau, Melody Lee & Christine Poulos. (2020) Insights into the choice between intravenous infusion and subcutaneous injection: physician and patient characteristics driving treatment in SLE. Clinical Rheumatology 40:2, pages 581-590.
Crossref
Crossref
Y. M. Chiu, M. T. Chuang & H. C. Lang. (2016) Medical costs incurred by organ damage caused by active disease, comorbidities and side effect of treatments in systemic lupus erythematosus patients: a Taiwan nationwide population-based study. Rheumatology International 36:11, pages 1507-1514.
Crossref
Crossref
Erin E. Carter, Susan G. Barr & Ann E. Clarke. (2016) The global burden of SLE: prevalence, health disparities and socioeconomic impact. Nature Reviews Rheumatology 12:10, pages 605-620.
Crossref
Crossref
John G. Hanly, Kara Thompson & Chris Skedgel. (2016) Utilization of Ambulatory Physician Encounters, Emergency Room Visits, and Hospitalizations by Systemic Lupus Erythematosus Patients: A 13-Year Population Health Study. Arthritis Care & Research 68:8, pages 1128-1134.
Crossref
Crossref
M Y Choi, M R W Barber, C E H Barber, A E Clarke & M J Fritzler. (2016) Preventing the development of SLE: identifying risk factors and proposing pathways for clinical care. Lupus 25:8, pages 838-849.
Crossref
Crossref
Andreas Jönsen, Frida Hjalte, Minna Willim, Katarina Steen Carlsson, Christopher Sjöwall, Elisabet Svenungsson, Dag Leonard, Christine Bengtsson, Solbritt Rantapää- Dahlqvist, Susanne Pettersson, Iva Gunnarsson, Agneta Zickert, Johanna T. Gustafsson, Lars Rönnblom, Ingemar F. Petersson, Anders A. Bengtsson & Ola Nived. (2016) Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts. Seminars in Arthritis and Rheumatism 45:6, pages 684-690.
Crossref
Crossref